Let's not talk about the share price for the moment.
CMP is only 30 million capitalization firm with leading products in sleep diagnostic, DWL and neuro-research medical equipment, dominating in Australia (No. 1), Japan(No. 1), USA(No. 3) and China(No. 1). Its future pipeline includes somfit(medical grade, wearable device), eHealth(remote monitoring of health) and driver vigilance system.
In terms of size, 30 million cap is extremely small for firms with leading technology in medical field and its profit could multiply, because its existing dominant position/network in 3 of the largest economies, USA, Japan and China provides a platform for it to introduce new products quickly.
In terms of future pipelines, wearable device, ehealth and driver vigilance, each sector already presents billions-dollar market, and all it takes is for CMP to be good at any one.
In terms of financial metrics, P/E of 15, moderate gearing ratio of 48%(debt/asset) to fuel growth, strong holding position from founder and management team. CMP's progressive initiative to lower its cost base.
In terms of technology, strong investment in R&D provides a competitive advantage to establish leadership in its fields and reputation.
Looking at other leading medical firms, you can judge the potential for CMP
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)